Medications for Parkinsonian Disorders

28 results

  • amantadine

    (amantadine)
    Alembic Pharmaceuticals Inc.
    Amantadine hydrochloride capsules are indicated for prophylaxis and treatment of influenza A virus infections and for treating parkinsonism and drug-induced extrapyramidal reactions. They are recommended during influenza outbreaks and in patients exhibiting parkinsonism symptoms, although they are less effective than some other treatments for Parkinson's disease.

  • amantadine hydrochloride

    (Amantadine Hydrochloride)
    Coupler LLC
    Amantadine Hydrochloride Tablets are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for treating idiopathic Parkinson's disease, postencephalitic parkinsonism, and drug-induced extrapyramidal reactions. They are not a substitute for vaccination and may have reduced efficacy due to viral resistance.

  • benztropine mesylate

    (BENZTROPINE MESYLATE)
    QUAGEN PHARMACEUTICALS LLC
    This drug is indicated as an adjunct therapy for all forms of parkinsonism and is also useful in controlling extrapyramidal disorders caused by neuroleptic drugs, excluding tardive dyskinesia.

  • benztropine mesylate

    (benztropine mesylate)
    TYA Pharmaceuticals
    This drug is indicated as an adjunct therapy for all forms of parkinsonism and for controlling extrapyramidal disorders (excluding tardive dyskinesia) caused by neuroleptic medications, such as phenothiazines.

  • benztropine mesylate

    (BENZTROPINE MESYLATE)
    Fresenius Kabi USA, LLC
    This drug is indicated as an adjunct therapy for all forms of parkinsonism and is also effective in controlling extrapyramidal disorders caused by neuroleptic drugs, excluding tardive dyskinesia.

  • benztropine mesylate

    (benztropine mesylate)
    Cardinal Health 107, LLC
    Benztropine mesylate tablets are indicated as an adjunct therapy for all forms of parkinsonism and for controlling extrapyramidal disorders caused by neuroleptic drugs, excluding tardive dyskinesia.

  • benztropine mesylate

    (Benztropine Mesylate)
    ScieGen Pharmaceuticals Inc
    Benztropine mesylate is indicated as an adjunct treatment for all forms of parkinsonism and for controlling extrapyramidal disorders (excluding tardive dyskinesia) caused by neuroleptic medications such as phenothiazines.

  • diphenhydramine

    (Diphenhydramine Hydrochloride)
    Micro Labs Limited
    Diphenhydramine hydrochloride injectable is indicated for adults and pediatric patients to manage allergic reactions, aid in anaphylaxis as an adjunct to epinephrine, treat motion sickness, and address parkinsonism when oral administration is impractical or contraindicated. Not for use in premature infants or neonates.

  • diphenhydramine

    (DIPHENHYDRAMINE HYDROCHLORIDE)
    Fresenius Kabi USA, LLC
    This drug is indicated for treating parkinsonism when oral therapy is not feasible, particularly in elderly patients intolerant to stronger agents, mild cases in other age groups, and in conjunction with centrally acting anticholinergic agents.

  • diphenhydramine hydrochloride

    (Diphenhydramine Hydrochloride)
    REMEDYREPACK INC.
    Diphenhydramine hydrochloride injectable is indicated for adults and pediatric patients (excluding premature infants and neonates) for treating allergic reactions, anaphylaxis as an adjunct therapy, motion sickness, and parkinsonism when oral administration is impractical or contraindicated.